Belite Bio (BLTE) Market Cap to FCF (2022 - 2026)
Belite Bio (BLTE) Market Cap to FCF (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Market Cap to FCF |
|---|---|---|---|---|---|
| 1 | Genmab A | 276,399.99 Bn | 276,398.47 Bn | 831.00 Mn | 311,261.25 |
| 2 | Akari Therapeutics | 1,217.26 Bn | 1,217.26 Bn | - | -111,613.73 |
| 3 | BeOne Medicines | 419.38 Bn | 414.59 Bn | 1.35 Bn | 375.87 |
| 4 | Vertex Pharmaceuticals | 126.54 Bn | 119.30 Bn | 2.59 Bn | 34.11 |
| 5 | Pharming | 110.17 Bn | 110.12 Bn | 65.80 Mn | 9,616.61 |
| 6 | Regeneron Pharmaceuticals | 64.97 Bn | 56.22 Bn | 3.31 Bn | 15.80 |
| 7 | Argenx Se | 56.44 Bn | 56.44 Bn | 1.18 Bn | - |
| 8 | Alnylam Pharmaceuticals | 40.09 Bn | 37.08 Bn | 959.66 Mn | 62.32 |
| 9 | Revolution Medicines | 37.15 Bn | 37.15 Bn | - | -35.13 |
| 10 | Belite Bio | 96.77 Mn | 96.77 Mn | - | -9.32 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 8, 2026 | -9.97 |
| Jul 7, 2026 | -10.33 |
| Jul 6, 2026 | -10.09 |
| Jul 2, 2026 | -9.60 |
| Jul 1, 2026 | -9.32 |
| Jun 30, 2026 | -10.08 |
| Jun 29, 2026 | -10.13 |
| Jun 26, 2026 | -9.74 |
| Jun 25, 2026 | -9.81 |
| Jun 24, 2026 | -9.87 |
| Jun 23, 2026 | -9.50 |
| Jun 22, 2026 | -9.63 |
| Jun 18, 2026 | -9.57 |
| Jun 17, 2026 | -9.71 |
| Jun 16, 2026 | -9.05 |
| Jun 15, 2026 | -9.44 |
| Jun 12, 2026 | -9.05 |
| Jun 11, 2026 | -8.96 |
| Jun 10, 2026 | -8.95 |
| Jun 9, 2026 | -9.26 |